|

Speed Manipulated Adaptive Rehabilitation Therapy Bike for Parkinson's Disease

RECRUITINGN/ASponsored by Kent State University
Actively Recruiting
PhaseN/A
SponsorKent State University
Started2022-04-11
Est. completion2024-12
Eligibility
Age50 Years – 79 Years
Healthy vol.Accepted
Locations1 site

Summary

Parkinson's disease (PD) is a progressive neurological disorder that results in slowness of movement, muscle stiffness, tremor, and postural instability. These symptoms significantly affect PD patients' quality of life, independence, and functional performance. There is currently no cure for PD, but symptoms can be treated with levodopa or deep brain stimulation surgery. Exercise-based rehabilitation has similar beneficial effects to surgical and pharmacological management without the potential negative side effects. Cycling-based interventions have been shown to increases motor function and mobility in individuals with PD. Specifically, benefits are greater when cycling cadence (revolutions per minute, RPM) is 30% greater than a self-selected pace. Although high cadence cycling improves motor function in individuals with PD, there is significant heterogeneity in individual responses. To maximize the treatment effects and minimize the heterogeneity of high-cadence cycling, it is important to determine patient-specific settings. Previous studies have shown that higher variability (entropy) of cadence leads to greater improvement in motor function. The entropy of cadence calculation will be utilized to understand how patient-specific settings can drive improvements. The purpose of this study is to determine patient-specific settings and measure the effects of high cadence stationary (i.e. dynamic) cycling on functional performance in individuals with PD. Volunteers with Parkinson's disease will complete 12 cycling sessions over a 1-month period and measures of motor function, quality of life, functional performance, mood and exercise readiness will be collected.

Eligibility

Age: 50 Years – 79 YearsHealthy volunteers accepted
Inclusion Criteria:

* Idiopathic Parkinson's disease
* 50-79 years of age
* no contraindications to exercise including cardiovascular disease or stroke

Exclusion Criteria:

* one or more major signs/symptoms of cardiovascular or pulmonary disease

Conditions2

Parkinson DiseaseParkinson's Disease

Locations1 site

Kent State University
Kent, Ohio, 44242
Ridgel Angela, PhD330-672-7495aridgel@kent.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.